DJIA 16,204.97 -211.61 -1.29%
NASDAQ 4,363.14 -146.42 -3.25%
S&P 500 1,880.05 -35.40 -1.85%
market minute promo

MannKind Corp (NASDAQ: MNKD)

0.97 -0.01 (-1.34%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MNKD $0.97 -1.34%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.97
Previous Close $0.98
Daily Range $0.94 - $1.02
52-Week Range $0.64 - $7.88
Market Cap $396.3M
P/E Ratio -3.07
Dividend (Yield) $0.00 (0.0%)
Volume 2,824,338
Average Daily Volume 8,285,175
Current FY EPS -$0.28

Sector

Healthcare

Industry

Drug Makers

MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website: http://www.mannkindcorp.com/

News & Commentary

Biotech's Dumbest CEO Moves in 2015

Which biotech CEOs are most ready to forget 2015?

MannKind Fails Twitter Like It Does Afrezza

MannKind's (MNKD) Investor Conference Call (Transcript)

Will MannKind (MNKD) Continue to Surge Higher?

Vetr Top Raters Upgrade MannKind To 5-Star Stock

Should You Bet On A MannKind Sale?

7 Stocks With Short Interests of 40% to 80% of Their Float

MannKind (MNKD) Shows Strength: Stock Moves 14% Higher

Here's the Case for and Against a MannKind Acquisition

Swirling rumors of a potential deal may be overly optimistic.

MannKind (MNKD) Stock Skyrocketing on Sale Speculation

See More MNKD News...

MNKD's Top Competitors

MNKD $0.97 (-1.34%)
Current stock: MNKD
GILD $85.14 (-1.78%)
Current stock: GILD
AMGN $145.04 (-3.25%)
Current stock: AMGN
BIIB $263.86 (-3.44%)
Current stock: BIIB